CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity.

[1]  M. Mueckler,et al.  Differential regulation of the HepG2 and adipocyte/muscle glucose transporters in 3T3L1 adipocytes. Effect of chronic glucose deprivation. , 1990, The Biochemical journal.

[2]  K. Chihara,et al.  Leptin Induces Mitogen-activated Protein Kinase- dependent Proliferation of C3H10T1/2 Cells* , 1997, The Journal of Biological Chemistry.

[3]  F. Alford,et al.  1 Growth hormone deficiency and cardiovascular risk , 1998 .

[4]  B. Bengtsson,et al.  Growth hormone and the metabolic syndrome. , 1999, Journal of endocrinological investigation.

[5]  H. Okamura,et al.  A Putative Transcription Factor with Seven Zinc-Finger Motifs Identified in the Developing Suprachiasmatic Nucleus by the Differential Display PCR Method , 1999, The Journal of Neuroscience.

[6]  H. Nakshatri,et al.  Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. , 1999, Biochemical and biophysical research communications.

[7]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[8]  J. Watson,et al.  B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR α-chemokine , 2000 .

[9]  I. Kurth,et al.  Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney–Expressed Chemokine (Brak) in Macrophage Development , 2001, The Journal of experimental medicine.

[10]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[11]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[13]  M. Fujimiya,et al.  NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice , 2003, Nature Medicine.

[14]  M. Linton,et al.  Macrophages, inflammation, and atherosclerosis , 2003, International Journal of Obesity.

[15]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[16]  O. Ohara,et al.  Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. , 2003, Immunology letters.

[17]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[18]  J. Cross,et al.  SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation , 2003, The EMBO journal.

[19]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[20]  A. El‐Naggar,et al.  BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells , 2004, Cancer Research.

[21]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[22]  W. Isaacs,et al.  Modulation of CXCL14 (BRAK) expression in prostate cancer , 2005, The Prostate.

[23]  G. Fantuzzi.  Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[24]  Lisa M. Ebert,et al.  Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. , 2005, Immunity.

[25]  R. Ferris,et al.  Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo1 , 2005, The Journal of Immunology.

[26]  U. V. von Andrian,et al.  Murine CXCL14 Is Dispensable for Dendritic Cell Function and Localization within Peripheral Tissues , 2006, Molecular and Cellular Biology.

[27]  K. Chihara,et al.  Gene expression profile in the heart of spontaneous dwarf rat: in vivo effects of growth hormone. , 2006, Biochemical and biophysical research communications.

[28]  H. Yonekawa,et al.  Disruption of CXC Motif Chemokine Ligand-14 in Mice Ameliorates Obesity-induced Insulin Resistance* , 2007, Journal of Biological Chemistry.